Correlation Between Ibio and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ibio and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ibio and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ibio Inc and Akero Therapeutics, you can compare the effects of market volatilities on Ibio and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ibio with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ibio and Akero Therapeutics.
Diversification Opportunities for Ibio and Akero Therapeutics
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Ibio and Akero is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Ibio Inc and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Ibio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ibio Inc are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Ibio i.e., Ibio and Akero Therapeutics go up and down completely randomly.
Pair Corralation between Ibio and Akero Therapeutics
Given the investment horizon of 90 days Ibio is expected to generate 2.21 times less return on investment than Akero Therapeutics. In addition to that, Ibio is 1.67 times more volatile than Akero Therapeutics. It trades about 0.04 of its total potential returns per unit of risk. Akero Therapeutics is currently generating about 0.15 per unit of volatility. If you would invest 1,882 in Akero Therapeutics on August 29, 2024 and sell it today you would earn a total of 1,335 from holding Akero Therapeutics or generate 70.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ibio Inc vs. Akero Therapeutics
Performance |
| Timeline |
| Ibio Inc |
| Akero Therapeutics |
Ibio and Akero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ibio and Akero Therapeutics
The main advantage of trading using opposite Ibio and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ibio position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.| Ibio vs. Jaguar Animal Health | Ibio vs. GeoVax Labs | Ibio vs. Ocugen Inc | Ibio vs. Tonix Pharmaceuticals Holding |
| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |